
A combination of two drugs, one already approved by the Food and Drug Administration, appears to be effective at shrinking pancreatic cancers in laboratory mice, according to a new study.
http://www.sciencedaily.com/releases/2015/09/150921133644.htm
A combination of two drugs, one already approved by the Food and Drug Administration, appears to be effective at shrinking pancreatic cancers in laboratory mice, according to a new study.
http://www.sciencedaily.com/releases/2015/09/150921133644.htm